SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neurocrine Biosciences (NBIX)
An SI Board Since July 1996
Posts SubjectMarks Bans Symbol
1834 74 0 NBIX
Emcee:  Billy Dunn Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1309not a very good deal, IMO. big difference, valuing the company in private/publiscaram(o)uche-12/15/2004
1308OT - Cortex private placement Well, that's life I suppose. At least Roger iIcebrg-12/15/2004
1307OT, cont'd. Cortex Announces $11.26 Million Private Placement Wednesday Decscaram(o)uche-12/15/2004
1306OK, thanks. So, Nance gets one mention, and is thus (thus far) lumped with &quoscaram(o)uche-12/15/2004
1305<i>I get "no such message"</i> Ah, you mean that literallnigel bates-12/15/2004
1304DOV's Arnold Lippa convinced the FDA to not require him to bring ocinaplan bNeuroInvestment-12/14/2004
1303>> Neurocrine Biosciences Announces Initiation of Phase I Trial With CRF1 scaram(o)uche-12/14/2004
1302>> Sheesh! Life-time achievements for two guys younger than I. {grumble, gscaram(o)uche-12/14/2004
1301I get "no such message".scaram(o)uche-12/14/2004
1300Neurocrine Biosciences Announces Initiation of Phase I Trial With CRF1 Antagonisscaram(o)uche-12/14/2004
1299LT yes, but looking over the course of last year, the cambodia testing was a sermopgcw-12/13/2004
1298We've already bestowed the honor on Gary Lyons. That's how we got in thscaram(o)uche-12/13/2004
1297Speaking of Martin, how about John Martin of Gilead? If you take a long-term viJohn Metcalf-12/13/2004
1296I'd say Kelly Martin...hmpa-12/9/2004
1295And a nomination from Zeta... Message 20841845nigel bates-12/9/2004
1294Meldrum has done well, except perhaps, regarding his taste in investment bankerstuck-12/9/2004
1293I'll third that, unless Abbott fold before Dec. 31st. <g>nigel bates-12/9/2004
1292Erik: I'll second that nomination. Stoll took some flak initially (not fromNeuroInvestment-12/9/2004
1291Thanks, nice proposal IMO. Anybody else have a nominee? Let's knock aroundscaram(o)uche-12/9/2004
1290>>biotech's CEO of the year, 2004?>> Good idea, Rick. I wouldIcebrg-12/9/2004
1289we traditionally discuss good CEOs in this thread. anybody have thoughts about scaram(o)uche-12/9/2004
1288Neurocrine Biosciences initiated with "neutral" - update Wednesday, DIcebrg-12/2/2004
1287Neurocrine Submits New Drug Application (NDA) for Indiplon Modified Release TablIcebrg-11/22/2004
1286<i>Headquartered in San Diego, Calif., Somaxon's lead clinical programscaram(o)uche-11/12/2004
1285Neurocrine Biosciences Announces Licensing Agreement With Almirall for ParkinsonIcebrg-11/10/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News